NCT05940987

Brief Summary

This study aims to explore whether regular telephone intervention in patients with chronic pancreatitis can improve their smoking cessation rate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
382

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

June 28, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

1.7 years

First QC Date

June 15, 2023

Last Update Submit

March 26, 2025

Conditions

Keywords

Smoking CessationPhone-based intervention

Outcome Measures

Primary Outcomes (1)

  • Biochemically Validated of 7-day Point Abstinence

    The primary outcome will be biochemical validation of Self-reported 7-day point-prevalence abstinence at month 2, 6, 12 after quit date.

    12 months

Secondary Outcomes (3)

  • Self-reported 7-day Point Abstinence

    12 months

  • Number of cigarettes smoked per day

    12 months

  • Fagerstrom Test of Nicotine Dependence (FTND) scores

    12 months

Other Outcomes (2)

  • Reduction in Tobacco Consumption

    12 months

  • Times of hospitalizations

    12 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants in the intervention group will receive one 20-30 minutes "5A" smoking cessation health consultation after enrollment; They will be given regular phone-based smoking cessation intervention once a week in the first month and once a month thereafter (15 times in total). Participants will be followed at 2, 6, 12 months, and cotinine urine test kits will be mailed to those who have self-reported smoking cessation at follow-up, which is used to confirm whether they have quitted smoking or not. (smoking cessation is defined as urine cotinine levels below 200 ng/mL).

Behavioral: Phone-based smoking cessation intervention

Control Group

NO INTERVENTION

Participants in the control group will receive one 20-30 minute "5A" smoking cessation health consultation after enrollment; Phone-based smoking cessation intervention will not be regularly given after enrollment.

Interventions

Participants who allocate to the intervention group will receive regular phone-based smoking cessation intervention by professional team.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and older living; 2.Patients diagnosed as chronic pancreatitis; 3.Self-reported smoking ≥ 5 cigarettes; 4.Urine cotinine levels ≥ 200 ng/mL; 5.Owning a phone; 6.Willing to provide informed consent to participate in the study.

You may not qualify if:

  • Patients diagnosed as pancreatic cancer within 2 years after diagnosing chronic pancreatitis; Patients diagnosed as groove pancreatitis or autoimmune pancreatitis;
  • Pregnant or lactating women;
  • Patients with life expectancy ≤ 12 months;
  • Comorbidities such as Alzheimer's disease, end-stage cancer, HIV, end-stage congestive heart failure, end-stage chronic obstructive pulmonary disease, uncompensated cirrhosis, renal failure;
  • Smoking e-cigarettes or other forms of non-burning tobacco.
  • Patients refused to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hostipal

Shanghai, Shanghai Municipality, China

Location

MeSH Terms

Conditions

Pancreatitis, ChronicSmoking Cessation

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHealth BehaviorBehavior

Study Officials

  • Liang-hao Hu, M.D.

    Changhai Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

June 15, 2023

First Posted

July 12, 2023

Study Start

June 28, 2023

Primary Completion

February 25, 2025

Study Completion

February 25, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations